Notable Mover: Cannabis Science Inc (CBIS), Earth Science Tech Inc (ETST), mCig Inc (MCIG)

Cannabis Science Inc (OTCMKTS:CBIS) showing dropped of -5.07% and closed at $0.0712, after gaining total volume of 33.70M shares. Its earnings per share (EPS) is -$0.01 and its beta value stands at -2.77 points and has total market capitalization of $159.94 million and a total of 2.31 billion outstanding shares.

Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phyto cannabinoid-based pharmaceutical products primarily in the United States. The company is involved in developing medicines for autism, blood pressure, cancer and cancer side effects, as well as for other illnesses comprising for general health maintenance. It also develops CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, the company offers an online video-based medical cannabis education system, including courses, such as medical cannabis law, medical marijuana, cooking, horticulture, and bud tending; and manufactures and distributes specialty horse and pet grooming and topical applications. It has a license agreement with Apothecary Genetics Investments LLC to produce various brand formulations for California medical cannabis market; and collaboration with IGXBio, Inc. to develop GenePro, a DNA-based immunotherapeutic drug. The company also has a collaborative research agreement with Dana Farber/Harvard Cancer Center to explore and develop cannabinoid medicines to fight cancer. Cannabis Science, Inc. is based in Colorado Springs, Colorado. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc.

Earth Science Tech Inc (OTCMKTS:ETST) reported the plunge of -9.72% and closed at $1.30, with the total traded volume of 78,554.00 shares. During last trade its minimum price was $1.12 and it gained its highest price of $1.41 and has a total of 40.91 million outstanding shares.

Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, sports, and alternative medicine worldwide. It focuses on non-prescription nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. The company also provides consulting services to the athletic facilities industry. Its marketing services include direct marketing, search engine optimization, public relations, email marketing, social media marketing, and development of referral programs. In addition, Earth Science Tech, Inc. retails health and wellness brands, as well as sports nutrition and dietary supplement products; and stocks and sells high grade cannabidiol rich hemp oil and products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in April 2014. The company was incorporated in 2010 and is headquartered in Boca Raton, Florida.

mCig Inc (OTCMKTS:MCIG) increased 5.81% closed at $0.246 and traded with total volume of 1.97M shares, while the average trading remained 4.32M shares. During last trade its minimum price was $0.24 and it gained the highest price of $0.25. Its market capitalization was $88.48 billion.

mCig Inc (MCIG) on February 1, 2017 announced it has entered into legally binding subscription agreements with Paul Rosenberg, Chairman and Chief Executive Officer and Michael Hawkins, Chief Financial Officer for the issuance of 25,000 newly issued Series A Preferred shares each. Under the agreements Mr. Rosenberg and Mr. Hawkins will subscribe for and purchase directly or through their own beneficially owned and controlled special purpose vehicle 25,000 shares of Series A Preferred stock each for a total purchase price of $200,000 ($100,000 each), or $4.00 per share, which equates to $0.40 per common share in conversion. In addition to the Series A Preferred stock, Mr. Rosenberg and Mr. Hawkins will each receive a five year warrant for an equal amount of common shares at $0.75 per share.

MCIG remains ultra conservative in its financing measures. The Company has a long history of self-supporting its operations and continues to protect its shareholders from a toxic debt strategy. Paul Rosenberg stated, “We will remain diligent in our financing strategies as we continue to expand operations and grow vertically and horizontally.”

Headquartered in Henderson, Nevada, mCig Inc. (MCIG ) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. MCIG has transitioned from a vaporizer manufacturer to an industry leading large scale, full service cannabis cultivation construction company with its Grow Contractors division currently operating in the rapidly expanding Nevada market. The company looks forward to growing its core competencies to service the Ancillary legal Cannabis, Hemp and CBD markets, with broader expansion to take place once federal laws change. For more information visit www.mcig.org.